Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local research is testing a potential new medication to see if it may reduce joint pain, blood in the stool, bloody stool, weight loss, and/or eye pain associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for 2 to 17 years old to join a Crohn’s disease (CD) trial to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Inflammatory bowel disease (including associated symptoms such as joint pain, failure to thrive, diarrhea, frequent fevers and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing CD and UC flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce rectal pain, mouth sores, cramps, malnutrition, and/or canker sores associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children and teens 2–17 years of age to join a CD research to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or Inflammatory bowel disease (including associated symptoms such as diarrhea with blood and pus, fatigue, diarrhea, chronic fatigue and/or anemia), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing gastrointestinal disease flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce cramps, kidney stones, diarrhea, weight loss, and/or liver disease associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people at least 2 years of age but under 18 to join a clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Crohn’s disease (including associated symptoms such as abdominal pain or cramping, inflammation of the bowel or intestine, cramps, malnutrition and/or liver disease), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing Crohn’s and UC flare-ups? Local Crohn’s disease (CD) clinical research is testing a potential new medication to see if it may reduce cramps, diarrhea, diarrhea, weight loss, and/or joint pain associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderate to severe UC (including associated symptoms such as abdominal cramps, perianal fistula, rectal pain, malnutrition and/or canker sores), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease (CD) clinical research is testing a potential new medication to see if it may reduce abdominal cramping, fatigue, rectal pain, chronic fatigue, and/or anemia associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease (CD) clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease (CD) clinical research to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or gastrointestinal disease (including associated symptoms such as joint pain, kidney stones, constant need to poop, weight loss and/or canker sores), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.